10 hours ago
Veradigm (MDRX) Receives a Buy from TD Cowen
In a report released yesterday, Charles Rhyee from TD Cowen maintained a Buy rating on Veradigm (MDRX – Research Report), with a price target of $8.00. The company's shares closed yesterday at $4.50.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Rhyee covers the Healthcare sector, focusing on stocks such as Charles River Labs, CVS Health, and Icon. According to TipRanks, Rhyee has an average return of 1.2% and a 47.49% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Veradigm with a $5.00 average price target.
The company has a one-year high of $11.80 and a one-year low of $3.00. Currently, Veradigm has an average volume of 210.6K.
